Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 16

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 16
---
 Senior Secured Notes Due Feb 2025 (1,000) Outstanding balance of RCF (extended to May 2027) (1,343) Total Debt Repayments • Proactive management of maturities through a leverage - neutral transaction • Positive re - rating by credit rating agencies • Very strong liquidity position and no meaningful maturities until Q4’27 • Credit market confidence and support remains strong • Strong syndicate of global banks supporting RCF extension Clear Runway on Deleverage Path Introductory Remarks Business Performance Financials Final remarks Annex Balance Sheet Balance Sheet De - Risking Substantially Progressed; Continued Focus on Organic Deleveraging 1 Cash and cash equivalents of €980m + unused credit facilities €1,279m - unused RCF facilities maturing in Nov 2025 c€399m

- 20 - Q4 2024 Results Nacho Abia Chief Executive Officer (CEO) Building on our Momentum to Secure Continued Future Success

- 21 - Q4 2024 Results Grifols remained focused on its strategic execution throughout the year FY2024 marked all - time highs in business performance and set the stage for continuous improvements in 2025 and onward Financial and operational improvements will be further reinforced by a strategic plan Double down on sustainable growth and further margin expansion Continue to prioritize free cash flow generation and deleveraging Recognition of best - in - class sustainability reinforces the highest level of commitment 01 02 03 04 05 06 Introductory Remarks Business Performance Financials Final remarks Annex Key Takeaways Building on Our Momentum to Secure Continued Future Success

- 22 - Q4 2024 Results ANNEX Sustainability

- 23 - Q4 2024 Results Sustainability | Our Sustainability Plan Our Sustainability Ambition is to Drive Sustainable growth by Embedding ESG Principles into our Core Strategy Solid community where all donors understand their impact and feel valued. And wealthier society by advancing social progress, supporting organizations and actively engaging with local communities Ongoing efforts to drive diversity, continuous development, equal opportunities, gender equality and overall employee well - being across our global talent pool Healthier society where all patients receive the treatment they need Promoting the common good by fostering healthy environments where people can live, work and play, and by raising awareness on the need to protect the planet Scientific progress that, guided by our pioneering spirit , addresses the needs of patients and protects the rights, safety and well - being of clinical - trial participants Placing human rights at the core of our practices by integrating